Home > Healthcare > Biotechnology > Biotechnology R&D > Healthcare 3D Printing Market

Healthcare 3D Printing Market Share

Report ID: GMI1997
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Healthcare 3D Printing Market Share

The market is characterized by the presence of several key players and a strong focus on services, technological innovation, and strategic partnerships. Leading companies are investing in advanced 3D printing technologies to enhance the quality and efficiency of medical devices and customized implants. Additionally, partnerships between healthcare providers, research institutions, and 3D printing technology companies are increasing, driving innovation and expanding the adoption of 3D printing solutions across various healthcare sectors. These collaborations are not only improving the availability and precision of patient-specific implants but also fostering advancements in bioprinting and personalized treatment protocols.

Healthcare 3D Printing Market Companies

Prominent players operating in the healthcare 3D printing industry include:

3D Biotek
3D Systems
Aprecia Pharmaceuticals
Aspect Biosystems
Cyfuse Biomedical
Dassault Systèmes
Envision TEC
Materialise
Metamorph 3D print services
Nano3D Biosciences
Oceanz
REGENHU
Renishaw
Stratasys
Xometry

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global healthcare 3D printing industry was valued at USD 2.9 billion in 2023 and is expected to grow at a CAGR of 18.6% from 2024 to 2032, driven by increasing R&D investments and expanding clinical applications.

The syringe-based segment generated USD 1.2 billion in 2023, primarily due to its precision and control in bioprinting applications.

North America healthcare 3D printing industry recorded USD 1.1 billion in 2023 and is anticipated to grow at a CAGR of 18% between 2024 and 2032, fueled by the adoption of advanced medical devices and personalized treatment approaches.

Key players in the industry include 3D Biotek, 3D Systems, Aprecia Pharmaceuticals, Aspect Biosystems, Cyfuse Biomedical, Dassault Syst